Clinical trial
Safety and Pharmacokinetics of Astaxanthin-Rich Carotenoid Extract (AstaFerm™) Administered as a Single Oral Dose to Healthy Adults
NCT03807050 is registered in ClinicalTrials.gov with NextFerm Technologies LTD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Pharmacokinetics of Astaxanthin-Rich Carotenoid Extract (AstaFerm™) Administered as a Single Oral Dose to Healthy Adults
- Lead sponsor
- NextFerm Technologies LTD
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 19, 2018
- Completion date
- February 1, 2019
- Enrollment
- 12 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
absorption; chemicals